Gluesenkamp Perez defends reproductive rights

In response to the Alliance for Hippocratic Medicine v. the U.S. Food and Drug Administration (FDA) decision to overturn the FDA’s 22-year approval of the abortion medication mifepristone, U.S. Rep. Marie Gluesenkamp Perez (WA-03) took action to help protect access to reproductive care.

Mifepristone is one of the two drugs used in routine medication abortion care and miscarriage management. If allowed to stand, the Alliance for Hippocratic Medicine v. FDA ruling could severely compromise access to medication abortion nationwide. The Fifth Circuit Court of Appeals on Thursday reaffirmed the FDA’s approval of mifepristone, while significantly limiting access.